Health authority fines substandard-imported drug importers

The Drug Administration of Vietnam August 22 said that it has fined five pharmaceutical companies which imported several substandard medications.

The drug administration also asked five importers to recall and re-export these medicines which fail to meet the standard or destroy these drugs as per regulation.

Truong Quoc Cuong, head of the Drug Administration of Vietnam, signed the decision to fine VND 100 million (US$ 4,723) each to five companies including the branch of the Central Pharmaceutical Company No. 1 and No. 3 in Ho Chi Minh City and the central city of Da Nang’s Hai Chau District; the National Phytopharma Joint-Stock Company in HCMC's District 1;  Sohaco Trading and Pharmaceutical Group JSC in Hanoi's Ba Dinh District and the Danang Pharmaceutical Medical Equipment Joint Stock Company in Da Nang City’s Hai Chau District.

In addition to fine, the health watchdog will stop receiving registration document of these companies in one month or six months.

Most of these companies have imported Indian-made substandard drugs. For instance the Central Pharmaceutical Company No. 1 imported six low quality drugs such as Korean Dea Han New Pharm Co.’s Proexen tablet, Indian-made Norash -20 skin cream manufactured by Raptakos, Brett&Co and India’s Santa Pharma Generix Atorvastatin 10mg tablet.

By Quoc Khanh - Translated by Uyen Phuong

Other news